Alethio Therapeutics
a biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs)
Website Oxford, United Kingdom
Amount raised
$90M
Round
Series A
Date raised
November 5, 2026
Founded
—
CompanyAlethio Therapeutics
LocationOxford, United Kingdom
InvestorsSofinnova Partners, RA Capital Management
Websitealethiotherapeutics.com
Founders
Get new raises like this every week
Free weekly list of newly funded startups and their founders.
About Alethio Therapeutics
a biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs)
- How much did Alethio Therapeutics raise?
- Alethio Therapeutics raised $90M in a Series A round on November 5, 2026. Investors include Sofinnova Partners, RA Capital Management.
- Who founded Alethio Therapeutics?
- Professors Adam Mead and Beth Psaila and Rohit Batta co-founded Alethio Therapeutics.
- Where is Alethio Therapeutics based?
- Alethio Therapeutics is based in Oxford, United Kingdom.